A Fulminant Case of Acute Respiratory Distress Syndrome Associated with Mycoplasma Pneumonia Treated with Nasal High-Flow Oxygen Therapy
Joint Authors
Namkoong, Ho
Kawakami, Naoki
Ohata, Takanori
Sakaguchi, Shinji
Saito, Fumitake
Yuki, Hideki
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-10-21
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Introduction.
The prognosis of mycoplasma pneumonia in adults is generally favorable, but a few patients show progression to acute respiratory distress syndrome (ARDS).
We have described the management of a patient who showed progression of mycoplasma pneumonia to ARDS.
Presentation of Case.
A 26-year-old male patient with no significant past medical or social history presented with a 5-day history of fever.
Following this, he was diagnosed with bacterial pneumonia and treated with tazobactam/piperacillin; however, he showed little clinical improvement with this treatment approach.
We diagnosed the patient with mycoplasma pneumonia with an antigen test and treated him with azithromycin and prednisolone.
Despite the appropriate antimicrobial therapy, his symptoms worsened and therefore we changed his oxygen therapy from a reservoir mask to nasal high-flow oxygen in addition to minocycline.
Consequently, with this treatment, he recovered from severe mycoplasma pneumonia.
Discussion.
In patients with severe pneumonia who experience respiratory failure, it has been reported that nasal high-flow oxygen therapy is not inferior to noninvasive positive pressure ventilation therapy regarding intubation rate.
In this case, induction of nasal high-flow oxygen therapy led to avoidance of ventilator management.
This is a valuable case report highlighting the optimal outcome of nasal high-flow oxygen therapy in a fulminant case of acute respiratory distress syndrome.
Conclusion.
In patients who present with severe mycoplasma pneumonia with respiratory failure, nasal high-flow oxygen therapy can help reduce the needs for ventilator management including intubation.
American Psychological Association (APA)
Kawakami, Naoki& Namkoong, Ho& Ohata, Takanori& Sakaguchi, Shinji& Saito, Fumitake& Yuki, Hideki. 2018. A Fulminant Case of Acute Respiratory Distress Syndrome Associated with Mycoplasma Pneumonia Treated with Nasal High-Flow Oxygen Therapy. Case Reports in Critical Care،Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1141488
Modern Language Association (MLA)
Kawakami, Naoki…[et al.]. A Fulminant Case of Acute Respiratory Distress Syndrome Associated with Mycoplasma Pneumonia Treated with Nasal High-Flow Oxygen Therapy. Case Reports in Critical Care No. 2018 (2018), pp.1-3.
https://search.emarefa.net/detail/BIM-1141488
American Medical Association (AMA)
Kawakami, Naoki& Namkoong, Ho& Ohata, Takanori& Sakaguchi, Shinji& Saito, Fumitake& Yuki, Hideki. A Fulminant Case of Acute Respiratory Distress Syndrome Associated with Mycoplasma Pneumonia Treated with Nasal High-Flow Oxygen Therapy. Case Reports in Critical Care. 2018. Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1141488
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1141488